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Abstract 
Introduction 
The pathogenesis of glaucoma is still unclear. The direct effect of elevated intraocular 
pressure (IOP) has been proposed as important risk factor for developing of glaucomatous 
optic neuropathy (GON) based on mechanical theory. Despite well controlled IOP, glaucoma 
still progress in some patients. Vascular theory suggested that insufficient blood supply 
causes GON. A combination of high IOP and inadequate ocular perfusion may theoretically 
accelerate GON lead to rapid progression and more severe disease. 
Objectives 
Our objectives are to compare the mean of arterial stiffness between POAG patients and 
controls and to compare the mean of arterial stiffness on severity and progression of POAG. 
Methodology 
110 Malay patients were recruited for this study. 55 patients were POAG while 55 were age 
and gender matched controls. Arterial stiffness was measured in pulse wave analysis ( PWA) 
and pulse wave velocity (PWV) parameters using sphygmocor device.  
Results 
Mean age was 66.9 ± 9.0 years in POAG group and 66.6 ± 8.9 years in controls. PWA was 
26.98 ± 6.15% in POAG and 25.90 ± 5.39% in controls while PWV was 15.73 ± 4.14 m/s in 
POAG and 15.18 ± 3.26 m/s in controls. There were no significant differences of PWA and 
PWV between the two groups. Meanwhile, no significant difference of PWA and PWV on 
the severity and progression of POAG were noted. However, PWV showed significant 
difference on progression of POAG after analysed with multivariate ANCOVA with p < 0.05. 
Conclusion 
In this study, there were no significant difference of arterial stiffness between POAG and 
controls and the severity of POAG. PWV was found to be significant on progression of 
glaucoma after controlling the confounding factors. 
 
 
 
  
ABSTRAK 
Introduction 
Patogenesis glaukoma masih kurang jelas. Berdasarkan kepada teori mekanikal, 
Kenaikan tekanan bola mata adalah satu faktor secara langsung menyebabkan 
glaukomatous saraf mata. Walaupun tekanan bola mata telah dikawal, glaukoma masih 
didapati berkembang di kalangan pesakit. Teori saluran darah mencadangkan 
kekurangan peruntukan darah menyebabkan glaukomatous saraf mata. Kombinasi 
tekanan mata tinggi dan kekurangan perfusi mata dijangka mempercepatkan keterukan 
dan perkembangan glaukoma. 
 
Objektif 
Objektif kami adalah membandingkan purata keanjalan saluran arteri antara pesakit 
glaukoma sudut terbuka dengan kumpulan kawalan dan juga dari segi keterukan dan 
perkembangan antara pesakit glaukoma sudut terbuka.   
 
Tatacara  
Seramai seratus sepuluh pesakit telah menyertai kajian ini. Lima puluh lima pesakit 
glaukoma yang dipilih telah diseratakan umur dan jantina dengan kumpulan kawalan. 
Semua pesakit telah menjalani pengukuran keanjalan arteri iaitu gelombang nadi dan 
kelajuan nadi dengan memakai alat Sphygmocor.  
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Keputusan  
Purata umur pesakit glaukoma adalah  66.9 ± 8.0 tahun manakala 66.6 ± 8.9 tahun bagi 
kumpulan kawalan. Purata analisa gelombang nadi adalah 26.98 ± 6.15 %  bagi pesakit 
glaukoma dan 25.90 ± 5.39 % bagi kumpulan kawalan (p=0.333). Purata kelajuan 
gelombang nadi adalah 15.73 ± 4.14 m/s bagi pesakit glaukoma dan 15.18 ± 3.26 m/s 
bagi kumpulan kawalan (p=0.443). Keputusan ini menunjukkan tiada perbezaan 
keanjalan arteri antara pesakit glaukoma dan kumpulan kawalan. Selain daripada itu, 
tiada perbezaan yang jelas didapati dari segi keterukan (p=0.608, p=0.344) dan 
perkembangan glaukoma (p=0.218, p=0.234). Walaubagaimanapun, kelajuan nadi 
didapati ada berkaitan dengan perkembangan glaukoma selepas dianalisasi oleh 
multivariate ANCOVA (p=0.036). 
 
Kesimpulan 
Kajian ini mendapati tiada perbezaan keanjalan arteri antara pesakit glaukoma dengan 
kumpulan kawalan. Di samping itu, kajian ini juga tidak mendapati perbezaan dari segi 
keterukan penyakit glaukoma dan pekembangannya. Namun demikian, kelajuan nadi 
menunjukkan perbezaan dengan perkembangan glaukoma selepas faktor mengeliru 
dikawal. 
 
Kata Kunci – glaukoma sudut terbuka, keanjalan arteri, analisa gelombang nadi, 
kelajuan gelombang nadi 
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INTRODUCTION 
1.1 Glaucoma 
1.1.1 Definition of glaucoma 
 
Glaucoma is a chronic degenerative optic neuropathy characterised by its specific 
appearance of optic nerve damage and visual field defect. The morphologic 
changes of optic nerve includes cupping and pale optic disc which is due to loss 
of retinal ganglion cells (Quigley and Green, 1979). It is one of the leading causes 
of irreversible blindness worldwide.  
 
Glaucoma can be divided into two major categories according to the angle 
structure: open angle and angle closure glaucoma. Open angle glaucoma is often 
associated with increased intraocular pressure (IOP), however in certain 
population, the IOP can be within normal limits, so called normal tension 
glaucoma (NTG).   
 
1.1.2 POAG 
 
Of the many types of glaucoma, primary open angle glaucoma (POAG) is the 
most common form of glaucoma (Quigley and Broman, 2006). POAG can occur 
with or without elevation of intraocular pressure (IOP). Open angle with elevation 
of IOP is called high tension glaucoma (HTG) whereas open angle without 
elevation of IOP is termed NTG (Foster et al., 2002). However, in many 
literatures both NTG and HTG are considered under the same category of POAG 
(Lewis et al., 1983; Miller and Quigley, 1987; Motolko et al., 1982; Yu et al., 
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1997). Elevated IOP is an important risk factor and remain the only modifiable 
risk factor for POAG (Le et al., 2003). The presence of positive family history of 
glaucoma is another risk factor (Wolfs et al., 1998). 
 
Glaucoma is a complex disease. There is no single standardised criteria for 
diagnosing glaucoma especially POAG. There are wide variation in between 
optic disc size and IOP in between populations. This should be taken into account 
when evaluating the optic disc for different ethnics. African is known to have 
largest cup disc ratio with intermediate in Asians and smallest in whites. (Tsai et 
al., 1995). The variation not only exist in different ethnic groups but within the 
same ethnics as well. Study showed that greater vertical cup-to-disc ratio (VCDR) 
is related to male sex, higher IOP and lower body mass index (BMI) in normal 
Malay population. (Amerasinghe et al., 2008)  
 
Thus, the relation in between CDR and visual field defect is complex and it is 
hard to standardise the measurements for each and every individual. Glaucoma 
cases can be classified according to three levels of evidence (Foster et al., 2002). 
First, the highest level of certainty requires optic disc abnormalities (VCDR > 
97.5
th
 percentile in the normal population) and visual field defect compatible with 
glaucoma. Second, if a visual field test could not be performed satisfactory, a 
severely damaged optic disc (VCDR > 99.5
th
 percentile of the normal population) 
would be sufficient to make the diagnosis. Lastly, if the optic disc could not be 
examined because of media opacity (no field test was possible), an IOP exceeding 
the 99.5
th
 percentile of the normal population, or evidence of previous glaucoma 
filtering surgery , may be taken as sufficient for a diagnosis of glaucoma.  
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Characteristics of glaucomatous field defects include symmetrical defect across 
the horizontal midline, located in the mid periphery, clustered in neighbouring 
test points, reproducible on at least two occasions, not explained by any other 
disease and with reliable indices. Apart from that, the glaucoma hemifield test 
(GHT) should be graded “outside normal limits” with a cluster of three 
contiguous points at the 5% level on the pattern deviation plot, using 24-2 test 
pattern of Zeiss Humphrey field analyser (Foster et al., 2002). 
 
The diagnosis of POAG is thus, based on these findings, depends on the existence 
of optic nerve damage characterised by specific characteristic of optic nerve 
changes and visual field defect. The status of IOP as defining characteristic of 
glaucoma has evolved over times. Previously, IOP of 21mmHg has been used as 
cut off point for definition (Ritch et al., 1996). 
 
The existence of NTG as separate disease is disputed by many (Iester and 
Mikelberg, 1999; Miller and Quigley, 1987; Motolko et al., 1982). Nonetheless, 
there is presence of evidence that reducing IOP in NTG patients can modify the 
nature of disease progression (Wilson, 1997; Zhao et al., 1998). In some NTG 
patients, despite lowering of the IOP, they continue to experience progressive 
visual field loss leading to irreversible loss of vision (CNTGS, 1998). Some 
patients with higher than normal IOP remain stable with small visual field 
deterioration (Kass et al., 2002). This implies that mechanical theory eg IOP is 
not the sole cause of glaucomatous neuropathy. 
 
4 
 
NTG as a subtype of POAG was found to have a median IOP of 20mmHg or less 
in 10 baseline measurement (CNTGS, 1998). To establish the diagnosis of NTG, 
one has to rule out other types of glaucoma and optic neuropathy. Clinical 
assessment with systemic comorbids and brain imaging is recommended in non 
glaucomatous optic neuropathy such as compressive optic neuropathy, ischemic 
optic neuropathy and etc (Kamal and Hitchings, 1998). 
 
        1.1.2  Epidemiology of POAG 
 
The prevalence of visual impairment and blindness were estimated by World 
Health Organisation (WHO) to be 285 million visually impaired and 39 million 
blind in 2010 (Pascolini and Mariotti, 2011). The most common visual 
impairment is uncorrected refractive error (43%) followed by cataract (33%) and 
glaucoma (2%). The most common causes of blindness is cataract (51%)  
followed by glaucoma (8%) . 
 
Several studies have been conducted regarding the prevalence of glaucoma with 
different ethnic groups and geographic distribution (Klein et al., 1992; Mitchell et 
al., 1996). In Beaver Dam Eye Study, the overall prevalence of definite open-
angle glaucoma was 2.1% with cases increased with age from 0.9% in people 43 
to 54 years of age to 4.7% in people 75 years of age or older (Klein et al., 1992). 
In Australia, The Blue Mountains Eye Study showed prevalence of POAG and 
OHT of 3.0% and 3.7% respectively  (Mitchell et al., 1996). 
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The Rotterdam Eye Study showed prevalence of POAG was 0.8% and men were 
double than women (Wolfs et al., 2000). The prevalence of glaucoma was 3.6% 
in Beijing Eye Study with POAG (2.6%) and PACG (1.0%) (Wang et al., 2010) . 
 
The Egna Neumarkt Study showed prevalence of glaucoma in Italy with high 
tension glaucoma (2.0%), OHT (2.1%) and PACG (0.6%) (Bonomi et al., 1998). 
However, prevalence of glaucoma in Japan was POAG (2.62%), OHT (1.37%) 
and PACG (0.34%) (Shiose et al., 1990).  
 
Rotterdam study seems to have to lowest prevalence of 0.8% , most probably due 
to recruitment of patients of only 55 years and above compare to most studies 
which includes 40 years and above. 
 
It is estimated that the number of glaucoma patients will be increased from 60.5 
million in 2010 to 79.6 million in 2020 (Quigley and Broman, 2006). South East 
Asia is estimated to have increment of 2.89% of glaucoma population with 3.81% 
of POAG and 3.72% of PACG world population by 2020.(Quigley and Broman, 
2006) The prevalence of glaucoma among Malay population in Singapore were 
3.4% of study population with POAG (2.5%), PACG (0.12%) and others 
(0.61%).(Shen et al., 2008). 
 
In Malaysia, National Eye Survey also showed that glaucoma is the fifth leading 
causes of blindness in 1996 (Zainal et al., 2002). In this study, the leading cause 
of blindness was cataract (39%) and uncorrected refractive error (48%) was the 
major cause of visual impairment. However, this study was conducted relied 
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solely on visual acuity, without biomicroscopy examination which may 
underestimate the prevalence of glaucoma. Clinic based study in urban population 
in Malaysia reported that glaucoma was the second most common eye disease in 
the eye clinic (SC Reddy, 2008) . The most common eye disease in this study was 
cataract (32.9%), followed by glaucoma (23.4%), refractive errors (10.8%) and 
diabetic retinopathy (9.7%). 
 
The incidence of glaucoma is expected to rise with the growth of elderly 
population. The disease is important to be diagnosed earlier for early therapy, not 
only to delay the progression but to reduce the cost of treatment as well. In the 
USA, glaucoma costs health care system an estimate of $2.5 billion annually 
which $1.9 billion represent direct cost and $0.6 billion represent indirect cost. 
The total annual direct cost of glaucoma treatment per patient can range from 
$523 in the early stage of glaucoma to $2125 in the advanced stage of glaucoma 
with mean of $1483 per patient.(Sponsel et al., 1995) This showed that the more 
severe the disease the higher the cost.  
 
However, the scope of the problem probably bigger than what we expected as 
there are still large proportion of individuals remains undiagnosed or inadequately 
treated (McKean-Cowdin et al., 2008). 
 
         1.1.3 Pathophysiology 
 
Under normal physiologic condition, as IOP increases, arterioles dilate to 
decreased vascular resistance in response to a decrease in pulse pressure, thus 
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maintaining a constant oxygen tension at the optic nerve. In healthy subjects, 
autoregulation has been shown to maintain constant ocular blood flow over a 
wide range of perfusion pressure  (Liu et al., 2003). Evidence showed that blood 
flow in both retina and optic nerve head was autoregulated by neural, endothelial 
and myogenic mechanism (Flammer and Mozaffarieh, 2008). Ocular blood flow 
had been shown to remain constant when the perfusion pressure was altered by 
intraocular pressure or systemic blood pressure (Schmetterer et al., 1997). 
 
Evidence suggest that subjects with glaucoma fail to adapt to changes in either 
IOP or blood pressure that cause fluctuations in perfusion pressure, ultimately 
resulting in unstable blood flow to the retina and optic nerve head (Harris et al., 
2001). In recent years, alterations in ocular blood flow and abnormal vascular 
autoregulation are emerging key components of the disease process in glaucoma. 
Compromised ocular blood flow and deranged vascular autoregulation in the 
optic nerve head could be as important as intraocular pressure (Flammer and 
Mozaffarieh, 2008; Hayreh, 2001).  
 
Various systemic and local factors can cause low perfusion pressure and 
breakdown of autoregulatory mechanism such as aging, hypertension, diabetes, 
hyperlipidemia, arteriosclerosis, atherosclerosis (Hayreh, 1995; Langham et al., 
1991; Werner et al., 2001).This results in unstable ocular perfusion and further 
ischemic and reperfusion damage.  
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Three components have been related to ocular blood flow reduction in glaucoma 
which are increased local resistance to flow, decreased ocular perfusion pressure 
and increased blood viscosity (Shaarawy et al., 2009). 
 
Local resistance to ocular blood flow can be due to either structural changes or 
functional changes. Structural changes such as anatomic variations in the vessels, 
obstruction of the lumen by thrombosis or arteriosclerosis and spasm whereas 
functional changes can be defective autoregulation of blood flow (Flammer et al., 
1999; Sharrett et al., 1999). Increased vascular stiffness can increase the 
resistance which may contribute to impaired autoregulation in certain glaucoma 
patients. Arterial stiffness can be affected by several factors such as age, 
hypertension, diabetes mellitus, hyperlipidemia and atherosclerosis (Blacher et 
al., 1999; Brouwers et al., 2009; Ogawa et al., 2005; Tomiyama et al., 2003; van 
Popele et al., 2001). 
 
Clinical trials had demonstrated inadequate blood flow in patients with POAG in 
retinal, choroidal and retrobulbar circulation (Butt et al., 1995; Chung et al., 
1999b; Yin et al., 1997). Abnormalities in ocular perfusion pressure, nocturnal  
hypotension, aging of vasculature, optic disc hemorrhage and migraine had  been 
reported to be associated with POAG (Bonomi et al., 2000; Drance et al., 2001; 
Hayreh et al., 1994; Leighton and Phillips, 1972). 
  
.  
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Siasos et al (2011) found out arterial stiffness is associated with POAG (Siasos et 
al., 2011). On the other hand, few studies shown no significant findings between 
arterial stiffness and POAG (Chiba et al., 2008; Graham et al., 2013). Therefore, 
arterial stiffness and POAG issue is still controversial and most studies are 
conducted in western countries. Therefore, a study of arterial stiffness on POAG 
in Malay patients could be beneficial to Malaysia as Malay represent one of the 
largest ethnic group in Southeast Asia.  
 
        1.1.4    Progression of POAG 
        1.1.4.1 Natural course of POAG 
 
The rate of progression in glaucoma patients receiving treatment was estimated at 
approximately 3% per year (Smith, 1985). However, this rate starts at the residual 
visual field of 70%. Study has also reported that POAG progression in untreated 
person from early to end stage had an average of 14.4 years if the IOP is in 
between 21-25 mmHg (Jay and Murdoch, 1993). The progression rate can be as 
long as 38 years if the disease is optimally treated with surgical intervention. The 
rate of progression varies individually with some eyes show curvilinear loss and 
some linear loss. 
 
Monitoring progression of glaucoma is a challenge for clinician. After glaucoma 
is diagnosed, serial IOP, cup to disc ratio (CDR), retinal nerve fibre layer (RNFL) 
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and visual field measurements will be conducted to monitor the progression. In 
some patients, progression can still be seen despite well controlled IOP. This 
could be due to other factors such as vascular factors causing progression of 
glaucoma (Schmidl et al., 2011). 
 
Morphological changes suggestive of progression can be evaluated with serial 
stereophotography of optic disc and optical coherence tomography (OCT) to 
assess any increase excavation of the neural rim with increase cup disc ratio, 
notching, rim thinning, disc hemorrhage and thinning of retinal nerve fibre layer.  
 
For functional changes, automated perimetry is used for visual field monitoring. 
Small sensitivity deficits in paracentral regions may initially extend and deepen, 
becoming arcuate in appearance and nasal step type defects may enlarge 
temporally (Mikelberg and Drance, 1984). Later, the defects will join with the 
physiological blind spot and widen. Worsened visual acuity is also used as a sign 
of progression in end stage patients with diffuse depressed visual field (Membrey 
et al., 2000).  
 
VF measures are not perfectly repeatable in normal individuals and can exhibit 
both short and long term variations (Spry and Johnson, 2002). This is even more 
obvious and greatly increased in glaucoma. It is a complex task to distinguish 
progressive glaucomatous visual field loss from test variability.  
 
The procedures used for detection of glaucomatous visual field progression can 
be grouped into four categories : 1) Clinical judgement, which consists of simple 
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subjective observation of sequential visual field test results (Heijl et al., 1990); 2) 
visual field defect classification systems, whereby specific criteria are used to 
stratify field loss by discrete score and define progression as score change over 
time, such as the CIGTS Scoring System (Musch et al., 1999) ; 3) trend analysis, 
which follow test parameters sequentially over time to determine the magnitude 
and significance of patterns within the data, for example linear regression 
(HOLMIN and Krakau, 1982); and 4) event analysis, which identify single events 
of significant change relative to a reference examination (Fankhauser and Jenni, 
1981).  
 
The natural course of NTG is variable, with some cases progress slowly without 
any treatment but others progress rapidly (Anderson and Drance, 2001). 
Collaborative Normal Tension Glaucoma Study Group (CNTGS) reported that 
lowering IOP by 30% showed a slower rate of visual field progression (Zhao et 
al., 1998). However, progression of the visual field damage continues in 20% of 
NTG patients even though IOP has been lowered 30% or more from the baseline 
(Zhao et al., 1998). 
 
Long term IOP fluctuation is associated with VF progression in patients with low 
mean IOP (Caprioli and Coleman, 2008). This could be due to greater IOP 
fluctuation in low mean IOP patients with further stress imposed on the nerve 
tissue and damages occurs. Vascular theory might be the contributing factor, 
though the IOP is controlled but disease still progress.  
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1.1.4.2 Definition of Progression 
 
There are few examples of definitions of visual field progression from 
multicenter clinical trials such as AGIS, EMGT and CIGTS.  
 
Early Manifest Glaucoma Trial Group ( EMGT ) studied on early glaucoma with 
mean deviation of -4 dB and median IOP of 20mmHg (Heijl et al., 2002). Visual 
field progression was defined as the same 3 or more test point locations showing 
significant deterioration from baseline on glaucoma change probability maps 
(GCPMs). Optic disc progression was determined by 2 masked graders using 
flicker chronoscopy plus side by side comparison by a third grader to decide if 
definite optic disc progression was present. Study revealed that by reducing IOP 
of 25% or more, the glaucoma progression was less frequent. (Heijl et al., 2002).  
 
Collaborative Initial Glaucoma Treatment Study (CIGTS) was done on newly 
diagnosed POAG patients with medically treated versus surgically treated group 
(Musch et al., 1999). The CIGTS scoring was based on Statpac Total Deviation 
Probability Maps rather than on decibel deviations. As with AGIS, only clustered 
depressed points counted, and the field score depended on the significance level 
of depression at each test location and its neighbours. The CIGTS final score 
ranged from 0 to 20. Progression required a worsening of MD by 3 or more dB 
compared with that at baseline. Study showed that patients who had advanced 
visual field damage and treated surgically had less visual field progression than 
those who treated medically (Musch et al., 2009). 
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AGIS study was carried out on patients with advanced glaucoma and aimed to 
look at the outcome of trabeculoplasty and trabeculectomy in these patients 
(Gaasterland et al., 2000). AGIS VF scoring was based on the number and depth 
of depressions from age related normal threshold value displayed in the Statpac 
Total Deviation maps of the Humphrey perimeter (Carl Zeiss Meditec, Dublin 
CA). The scores ranged from 0 (normal) to 20 (worst field status). Reductions of 
sensitivity must have met certain minimum criteria to be considered: for example, 
hemifield defects must have consisted of at least 3 clustered test point locations 
with depressed sensitivity in the same superior or inferior hemifield. The 
maximum field score was 9 in each hemifield plus 2 in the nasal area. The 
glaucoma progression was defined as worsening of the score by at least 4 units, 
compared to the baseline reference field in 3 consecutive tests. Study showed that 
patients with IOP consistently below 18 mmHg was almost no visual field loss. 
 
Comparison had been done on the various methods of scoring system namely 
AGIS, CIGTS and EMGT. Joanne Katz et al (1999) reported that the detection 
rate of progression using AGIS, CIGTS and EMGT scoring was 11%, 22% and 
23% respectively (Joanne Katz, 1999). In addition, clinical assessment of 
progression is almost identical to EMGT scoring. In this study, it was found 
agreement between clinician was better than scoring methods (Joanne Katz, 
1999). However, Werner and colleague (1988) reported that scoring method was 
better than clinician agreement (Werner et al., 1988). Therefore, it is still difficult 
to determine which of analytical methods is the best in classifying glaucoma 
progression. Visual fields that appear progress over time may improve at 
subsequent visits. Separating true progression from visual field fluctuations is not 
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an easy task due to patients learning effects, fatigue and physiological state of the 
eye (Medeiros and Alencar, 2010). 
 
As a general rule, visual field should not be using as stand alone test to monitor 
progression. Xin et al (2011) reported that calculating progression showed poor 
agreement if only visual field or stereophotograph alone was used. Thus, 
combination of functional and structural test when determining progression is 
recommended (Xin et al., 2011). 
 
 1.1.4.3 Factors affecting progression in POAG 
 
Prognostic factors for glaucoma progression have been studied in large multi 
centre randomised clinical trials. 
 
Age has been shown as progression risk factor in several studies include EMGT 
and AGIS study (De Moraes et al., 2011; Gordon et al., 2002; Leske et al., 2007; 
Musch et al., 2009; Nouri-Mahdavi et al., 2004). 
 
Apart from age, baseline high IOP and  IOP fluctuation are also an important risk 
factor (Gordon et al., 2002; Leske et al., 2007; Nakagami et al., 2006; Nouri-
Mahdavi et al., 2004). 
 
Elevated IOP during follow up was a strong factor for glaucoma progression with 
the hazard ratio increasing by 11% for every 1 mmHg of higher IOP in EMGT 
study (Bengtsson et al., 2007). IOP dependent parameters such as mean IOP 
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follow up, peak IOP and IOP fluctuation were also noted to be associated with 
increased risk of progression (De Moraes et al., 2011). Patients with higher mean 
IOP follow up tends to have higher peak IOP. 
 
In EMGT study, disc hemorrhage and thinner CCT are also significant glaucoma 
progression factors (Leske et al., 2007). On the other hand, longer follow up and 
higher number of glaucoma interventions are associated with visual field 
progression in AGIS study (Nouri-Mahdavi et al., 2004). In addition, increase 
nerve fibre layer thinning, concurrent glaucoma therapy, CDR asymmetry and 
disc crescent play a role in the progression of OHT to POAG (Quigley et al., 
1994). 
 
Female gender, migraine and disc hemorrhage have also reported to be the risk 
factors associated with progression in NTG (De Moraes et al., 2011; Drance et 
al., 2001). Variable rate of deterioration, as well as lack of progression in a 
substantial number suggest IOP might not be the only contributing factor. 
Vascular factors might play a role in glaucoma progression. 
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1.2  Macrovascular  Arterial stiffness 
 1.2.1 Mechanism of arterial stiffness   
 
The pathogenesis of glaucoma is still unclear today. Both mechanical and 
vascular theory has been proposed (Fechtner and Weinreb, 1994). The 
mechanical theory suggests that elevated IOP is important risk factor for 
developing of glaucomatous optic neuropathy. Increased IOP causes stretching of 
the laminar beams which leads to bowing of lamina cribosa and damage the 
retinal ganglion cells (Emery et al., 1973). The vascular theory postulates 
glaucomatous optic neuropathy was due to insufficient blood supply caused by 
vascular dysregulation leading to unstable ocular perfusion, causing further 
ischemia and reperfusion damage. (Flammer et al., 2002). 
 
Various mechanism of vascular regulatory dysfunctions have been proposed such 
as atherosclerosis, vasospasm, and endothelial dysfunction that could contributes 
to reduced ocular blood flow (Moore et al., 2008). Vascular dysregulation can be 
caused by loss of ability of autoregulation of blood to maintain ocular blood flow 
with adequate oacular perfusion despite changes in local vascular parameters 
(Flammer and Mozaffarieh, 2008). 
 
.   
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Arterial stiffness was described as reduced capability of an artery to expand and 
contract in response to pressure changes (Bramwell and Hill, 1922). Elasticity of 
the arteries are important to smoothen flow from intermittent ventricular ejection 
to more steady flow within the peripheral tissues. During systole, the artery which 
contains high elastin fibre allows distension whereas during diastole, the blood is 
pushed forward through the arterial tree due to its elastic recoil properties. More 
distal arteries have lesser elastic fibres that makes them less distensible (Roach 
and Burton, 1957). The increase of arterial stiffness that occurs with age is largely 
due to degeneration of the elastic fibres (Avolio et al., 1998). There is a 
possibility that a combination of mechanical and vascular accelerate the disease 
progression (Chung et al., 1999a). 
 
In healthy and compliant arteries, the pressure wave from left ventricles travels  
through the arterial trees and reflected at multiple peripheral sites. As a result, the 
arterial pressure waveform at any site is a combination of forward travelling 
waveform and backward reflection waveform. The two waveforms merge during 
diastole and augment coronary perfusion. As the arterial wall thickens and stiffer 
with aging, the pressure waves travel faster and reflected pressure wave returns 
during the systolic phase,  increasing the systolic pressure and thus increasing left 
ventricular load (Nichols et al., 2011). Arterial stiffness can lead to a fall in 
diastolic pressure resulting in widened pulse pressure which can cause organ 
impairment due to greater pressure fluctuation (O’Rourke and Safar, 2005). 
Arterial stiffness is increased by three mechanism, namely 1) the breakdown of 
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the elastic structure, 2) damage to the endothelium or smooth muscle and 3) 
increase in mean arterial pressure. 
 
         1.2.2 Various methods of arterial stiffness measurements 
 
Commonly measured indices of arterial stiffness include compliance, 
distensibility, elastic modulus, pulse wave velocity, stiffness index and 
augmentation index (AIx) (Oliver and Webb, 2003). There are few non invasive 
methods of assessing arterial stiffness namely sphygmocor, arterial 
ultrasonography, magnetic resonance imaging (MRI), carotid augmentation index 
(AIx) and digital pulse contour analysis (DPCA). They can be compared in terms 
of ease of use, quality of validation, affordability, freedom from operator bias, 
evidence of prognostic value and endothelial function testing. PWV is deemed to 
have highest prognostic value among all (Laurent et al., 2006; Oliver and Webb, 
2003).     
 
1.2.3 Arterial stiffness measurement device (Sphygmocor) 
 
Sphygmocor is a simple to use, non invasive and accurate device for arterial 
stiffness measurement . The principle of applanation tonometry is used to obtain a 
high fidelity signal without penetrating the skin or blood vessels (Siebenhofer et 
al., 1999). Sphygmocor system consists of desktop PC, electronic module, 
tonometer probe and footswitch. In this system, the peripheral arteries mainly the 
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carotid, femoral or radial artery is flattened between the probe and the underlying 
structure. The intra arterial pressure pulse is then transmitted through the wall of 
the artery and the underlying tissue to the sensor in the tonometer and the result is 
generated by the computer (Sandy et al., 2006). 
 
The velocity of the blood pressure pulse waveform is dependent on the stiffness 
of the artery along which the pulse is travelling. It is the speed of the pressure 
wave travelling along an arterial segment. The higher the velocity, the more 
stiffness the artery is (Mackenzie et al., 2002) 
 
The device is available in portable form, therefore, useful in both hospital and 
clinic settings. Results of reproducibility will depend on both the stability of the 
subject’s physiological status and operator skill (Sandy et al., 2006). Although 
there are numbers of methods and devices to measure arterial stiffness either 
systemic, regional or locally, Sphygmocor is one of the device which is not only 
measuring the pulse wave velocity (PWV) but also pulse wave analysis (PWA) 
(Laurent et al., 2006). 
                              
1.2.4 Pulse Wave Analysis (PWA) 
 
The amount of augmentation pressure is quantified in terms of the relative change 
over the whole pulse. For PWA, the tonometer will be placed and compressed 
gently on the radial artery until a consistent pressure waveform is displayed 
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between the upper and lower display limits and the data will be captured. From 
peripheral measurements, the PWA software derives the central aortic blood 
pressure waveform and a range of central arterial indices of ventricular – vascular 
interaction will be displayed. Once the early systolic shoulder (peak, P1) or the 
late systolic shoulder (P2) are identified, the difference between P1 and P2 will be 
expressed as a percentage of the pulse pressures which is calculated as 
augmentation index (AIx) (Mackenzie et al., 2002; Sandy et al., 2006). 
 
The AIx was analysed in terms of the relationship to pulse wave reflection and 
global arterial stiffness. Comparison between AIx and PWV has shown a 
significant association, with a significant but relatively weak positive correlation 
found between AIx and aortic PWV (r=0.29, p<0.005) (Brown, 1999). 
 
1.2.5 Pulse Wave Velocity (PWV)  
 
PWV is the speed at which the forward pressure is transmitted from the aorta 
through the vascular tree. It is calculated by measuring the time taken for the 
arterial waveform to pass between two points with a measured distance apart and 
involves taking readings from two sites. PWV is measured when the tonometer 
placed and compressed gently on the carotid and femoral artery with ECG 
electrodes attached to the subject’s chest area. The analysis will be done by the 
software and reading will be shown on the screen (Mackenzie et al., 2002; Sandy 
et al., 2006). 
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PWV is associated with wave reflection phenomenon of the central aortic 
waveform obtained by means of a transfer function from peripheral recordings of 
the arterial pulse. Reproducibility assessed through the Bland-Altman method 
with calculation of the repeatability coefficient was, following intraobserver  
comparison, for brachial PWV: 1.64m/sec (for a mean value of 8.65±1.58 m/sec); 
and for aortic PWV:2.34m/sec (for mean value of 8.15±3.01 m/sec). 
Corresponding data for between-observer values were 2.18m/sec and 2.50 m/sec, 
respectively (Wilkinson et al., 1998). 
 
         1.2.6 Effect of arterial stiffness on glaucoma 
 
Low arterial elasticity is associated with increased risk of hypertension (Liao et 
al., 1999) and untreated hypertension may accelerate the rate of large arterial 
stiffness and thus perpetuate vicious cycle of accelerated hypertension and further 
stiffen the arteries (Franklin et al., 1997). 
 
Studies have shown strong association of arterial stiffness and atherosclerosis 
(Hirai et al., 1989; van Popele et al., 2001). Atherosclerosis is a chronic, 
progressive systemic disease which normally develops slowly with formation of 
fatty streak and atherosclerotic plaque. The lesion can cause blood flow limitation 
with either lumen narrowing or occlusion of the vessel due to rupture of the 
plaque with thrombus formation (Davies, 1995).  
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Arterial stiffness was also found to be associated with higher cardiovascular 
mortality such as heart failure and stroke (Blacher et al., 1999; Sutton-Tyrrell et 
al., 2005) and chronic kidney disease (Baumann et al., 2014). Although the 
relationship between arterial stiffness and OAG has been reported, the answer is 
still inconclusive. 
 
There are few studies regarding association of glaucoma with arterial stiffness. 
Siasos et al (2011) found out POAG patients had increased arterial stiffness, 
impaired endothelial dysfunction and increased inflammatory status (Siasos et al., 
2011). It is interesting to discover that retinal arteriolar and venular diameters are 
found narrowed during normal aging due to age associated vascular rigidity and 
atherosclerosis (Leung et al., 2003). On the other hand, Chiba et al (2008) 
reported that systemic arterial stiffness seems not to be strongly associated with 
glaucoma (Chiba et al., 2008). Moreover, another study showed there was only 
minor difference of waveform parameters between glaucoma and normal 
participants which did not show any relationship between arterial stiffness and 
glaucoma in study by Graham (Graham et al., 2013). 
     
Despite well controlled IOP, glaucoma still progress in significant number of 
patients. Vascular factor has been suggested decades ago but yet little is known. 
Adequate ocular blood flow is as important as reduction of IOP in preventing 
further glaucomatous damage.  
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The purpose of the study is to focus on vascular changes especially arterial 
stiffness as risk factors for disease progression and try to advocate an additional 
route in the pathogenesis of glaucomatous optic neuropathy. A combination of 
high IOP and inadequate ocular perfusion may theoretically accelerate the 
glaucomatous optic neuropathy lead to rapid progression and more severe 
disease. To the best of our knowledge, study of arterial stiffness on severity and 
progression of POAG is very limited. Early detection of systemic arterial stiffness 
might reduce the severity and progression of glaucoma by targeting and 
emphasizing modifiable habits earlier. 
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2.1 General Objective 
 
To evaluate the effects of arterial stiffness on severity and progression of primary 
open angle glaucoma (POAG). 
 
2.2 Specific Objectives 
 
1. To compare the mean of arterial stiffness between POAG patients and  
     controls. 
2. To compare the mean of arterial stiffness on severity of POAG. 
3. To compare the mean of arterial stiffness on progression of POAG. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
